Company Description About Bicycle Therapeutics Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic
Manager, Deal Finance & M&A Location: Cambridge UK Introduction to the Role: AstraZeneca continues to pursue value-enhancing transactions that supplementitsproduct portfolio and development pipeline, and to deliver maximum value from existing assets through the partnerships, collaborations,
Were building a connected, end-to-end Enterprise AI engine - uniting data foundations, AI technology, process reinvention, and business-facing AI to accelerate results across the whole value chain. Success depends on being outstanding connectors: youll actively harness existing
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a novel class of medicines, referred to as Bicycle® molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small
Manager, Deal Finance & M&A Location: Cambridge UK Introduction to the Role: AstraZeneca continues to pursue value-enhancing transactions that supplementitsproduct portfolio and development pipeline, and to deliver maximum value from existing assets through the partnerships, collaborations,
AstraZeneca continues to pursue value-enhancing transactions that supplement its product portfolio and development pipeline, and to deliver maximum value from existing assets through the partnerships, collaborations, out-licences and divestments that create value and share risk. AstraZeneca